Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PAB4903 - Provider product page
- Provider
- Abnova Corporation
- Proper citation
- Abnova Corporation Cat#PAB4903, RRID:AB_1574024
- Product name
- CLDN1 polyclonal antibody
- Antibody type
- Polyclonal
- Description
- Rabbit polyclonal antibody raised against synthetic peptide of CLDN1.
- Storage
- Store at 4°C. For long term storage store at -20°C.Aliquot to avoid repeated freezing and thawing.
Submitted references Claudin-1 and claudin-5 expression patterns differentiate lung squamous cell carcinomas from adenocarcinomas.
Selective up-regulation of claudin-1 and claudin-2 in colorectal cancer.
Decreased expression of claudin-1 correlates with recurrence status in breast cancer.
Paschoud S, Bongiovanni M, Pache JC, Citi S
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2007 Sep;20(9):947-54
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2007 Sep;20(9):947-54
Selective up-regulation of claudin-1 and claudin-2 in colorectal cancer.
Kinugasa T, Huo Q, Higashi D, Shibaguchi H, Kuroki M, Tanaka T, Futami K, Yamashita Y, Hachimine K, Maekawa S, Nabeshima K, Iwasaki H, Kuroki M
Anticancer research 2007 Nov-Dec;27(6A):3729-34
Anticancer research 2007 Nov-Dec;27(6A):3729-34
Decreased expression of claudin-1 correlates with recurrence status in breast cancer.
Morohashi S, Kusumi T, Sato F, Odagiri H, Chiba H, Yoshihara S, Hakamada K, Sasaki M, Kijima H
International journal of molecular medicine 2007 Aug;20(2):139-43
International journal of molecular medicine 2007 Aug;20(2):139-43
No comments: Submit comment
Supportive validation
- Submitted by
- Abnova Corporation (provider)
- Main image
- Experimental details
- Western blot analysis of CLDN1 polyclonal antibody (Cat # PAB4903) in Jurkat cell lysate (35 ug/lane). CLDN1 (arrow) was detected using the purified polyclonal antibody (1 : 60 dilution).
Supportive validation
- Submitted by
- Abnova Corporation (provider)
- Main image
- Experimental details
- Formalin-fixed and paraffin-embedded human hepatocellular carcinoma reacted with CLDN1 polyclonal antibody (Cat # PAB4903) , which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry ; clinical relevance has not been evaluated.
- Validation comment
- Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)
